Skip to content

The effect of transcutaneous auricular vagus nerve stimulation on postoperative gastrointestinal function in patients undergoing lumbar spinal fusion: A single-center, prospective, randomized, double-blind, controlled study

The effect of transcutaneous auricular vagus nerve stimulation on postoperative gastrointestinal function in patients undergoing lumbar spinal fusion: A single-center, prospective, randomized, double-blind, controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097666
Enrollment
Unknown
Registered
2025-02-24
Start date
2025-03-14
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative gastrointestinal dysfunction

Interventions

Control group:transcutaneous auricular vagus nerve stimulation(Earlobe area)

Sponsors

Huzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 79 Years

Inclusion criteria

Inclusion criteria: 1. patients undergo for lumbar spinal fusion scheduled operation under general anesthesia; 2. ASA I-III; 3. age 18-79 years old, both sexes; 4. BMI in the 18.5-34.5 kg/m^2 range; 5. first lumbar spinal fusion; 6. All subjects voluntarily participated in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. The skin at the stimulation site of the ear vagus nerve may be damaged, swollen or infected due to the injury; 2. Preoperative malnutrition (the nutritional assessment standard mainly relies on serum albumin, with albumin < 35g/L); 3. Preoperative moderate or above anemia; 4. Preoperative gastrointestinal dysfunction or disorder, chronic gastrointestinal diseases, including chronic gastritis, gastric ulcers, etc.; 5. Preoperative tinnitus, arrhythmia, etc.; 6. Patients with artificial devices such as cardiac pacemakers; 7. History of major abdominal surgery in the past; 8. Chronic pain, neuropathic pain, and those who have been using analgesics or other psychotropic drugs for a long time; 9. Comorbid with neurological and mental disorders, infections, severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, hematological diseases, etc.

Design outcomes

Primary

MeasureTime frame
The time of the first flatus after the surgery;The time of the first defecation after the operation;

Secondary

MeasureTime frame
Serum gastrin level;Gastrointestinal symptom score;The time of the first meal after surgery;Pain score;The levels of inflammatory factors in the blood;Restoration Quality Score;Depression score;Sleep Quality Index;Postoperative nausea and vomiting score;Length of hospital stay;Hospitalization expenses;The time of the first postoperative ambulation ;The number of patients who received postoperative rescue analgesia and the dosage of drugs used;

Countries

China

Contacts

Public ContactLingling Sun

Huzhou Central Hospital

604560528@qq.com+86 187 6729 2330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026